Concepedia

Publication | Open Access

A randomized controlled trial with everolimus for IQ and autism in tuberous sclerosis complex

DOIFull Paper Access

125

Citations

18

References

2019

Year

Iris E. Overwater, André B. Rietman, Sabine E. Mous, Karen Bindels‐de Heus, Dimitris Rizopoulos, Leontine W. ten Hoopen, Thijs van der Vaart, Floor E. Jansen, Ype Elgersma, Henriëtte A. Moll,
Neurology

Abstract

This study provides Class I evidence that for children with TSC, everolimus does not improve intellectual disability, autism, behavioral problems, or other neuropsychological deficits.

References

YearCitations

Page 1